Climb Bio CLYM
NASDAQ CLYM
$11.74 +0.72 (+6.53%)
At close: Nov 10, 2026 · 4:00 PM EST

Climb Bio (CLYM) EV to FCF (2024)

Updated

Climb Bio's (CLYM) EV to FCF was -129.03 for Q2 2024.

Analysis

Climb Bio (CLYM) EV to FCF (2024) Analysis & Trends

Over the twelve months ended Jun 30, 2024, Climb Bio's EV to FCF came in at -5730.12.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Climb Bio 939.56 Mn 340.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -129.03
API Access

Climb Bio EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=CLYM&period=max&api_key=YOUR_API_KEY